Trevor Cook joined Bird & Bird in 1974 with a degree in chemistry from Southampton University. He was admitted as a Solicitor in 1977, joining the Intellectual Property Group of Bird & Bird, where since 1981 he has been a partner. He is Treasurer of the UK Group of the AIPPI (The International Association for the Protection of Industrial Property), Secretary to the British Copyright Council Standing Committee on Copyright and Technology, and a member of the Council of the Intellectual Property Institute. In addition to numerous articles Trevor has authored the following books - The Protection of Regulatory Data in the Pharmaceutical and Other Sectors (Sweet & Maxwell 2000), A User’s Guide to Patents (Butterworths 2002, Tottel - in press), A European Perspective as to the Extent to Which Experimental Use, and Certain Other, Defences to Patent Infringement, Apply to Differing Types of Research (Intellectual Property Institute 2006) and is working on a new edition of Pharmaceuticals Biotechnology and the Law (Macmillan 1991, LexisNexis Butterworths - in press). He co-authors Practical Intellectual Property Precedents (Sweet & Maxwell 1998 to date) with Audrey Horton and co-authored The Copyright Directive (Jordans 2004) with Lorna Brazell. He is one of the General Editors of The Modern Law of Patents (LexisNexis Butterworths 2005). He contributes to the Chartered Institute of Patent Agents European Patents Handbook (Sweet & Maxwell) and to Vaughan & Robertson’s Law of the European Union (Richmond Law and Tax). He also contributed to both editions of Information Technology and the Law (Macmillan 1986, 1990), to the Third and Fourth Editions of the Chartered Institute of Patent Agents Guide to the Patents Act 1977 (Sweet & Maxwell 1990, 1995) and to Database Law (Jordans 1998).
Significant reported cases in the last ten years in which he acted for one of the parties to the litigation include, in the area of regulatory law, the references to the European Court of Justice in R v Licensing Authority, ex parte Generics (UK) Ltd, R v Licensing Authority, ex parte The Wellcome Foundation Ltd and R v Licensing Authority, ex parte Glaxo Operations UK Ltd and others [1999] 2 CMLR 181, R (On the application of Novartis Pharmaceuticals UK Ltd) v The Licensing Authority Established by the Medicines Act 1968 (acting by The Medicines Control Agency) and Others [2004] 2 C.M.L.R. 26 and Approved Prescription Services v MCA, Lilly intervening, in which judgment was given on 9 December 2004 and, in the area of intellectual property, Merrell Dow Pharmaceuticals v HN Norton [1996] RPC 76, Harrods v Harrodian School [1996] RPC 697, Beloit Technologies v Valmet Paper Machinery [1997] RPC 489, Sepracor v Hoechst Marion Roussel [1999] FSR 746, Unilever v The Procter & Gamble Co [1999] FSR 849, Oxford Gene Technology v Affymetrix [2001] FSR 136, Lilly-ICOS v Pfizer [2001] FSR 16, [2001] IP&T 190, Kirin-Amgen v Transkaryotic Therapies [2001] IP&T 882, [2002] RPC 1, [2002] RPC 2, [2002] RPC 3, [2002] RPC 43, [2003] RPC 3, [2005] IP&T 352, [2005] RPC 9, and Ranbaxy v Warner Lambert [2005] EWHC 2142, [2006] FSR 14, [2006] EWCA Civ 876.
